Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guilu Erxian Oral Liquid is a Traditional Chinese Medicine (TCM) formulation developed by Shandong Dong'e Ejiao Co., Ltd. It is primarily indicated for the treatment of conditions associated with Kidney Yang and Essence deficiency, including spermatorrhea, impotence, oligozoospermia, and asthenospermia. The formulation is a liquid version of the classic Guilu Erxian decoction, which typically contains four key ingredients: Deer Antler (Lujiao), Tortoise Plastron (Guiban), Ginseng (Ren-shen), and Wolfberry (Gou-qi-zi). Its therapeutic mechanism involves warming the kidney, replenishing essence, and nourishing blood to improve reproductive health and physical vitality. Clinical trials have focused on its efficacy and safety in improving sperm parameters and treating male infertility symptoms associated with Kidney Essence deficiency.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Guilu Erxian Oral Liquid.